Login / Signup

Peptide ARHGEF9 Inhibits Glioma Progression via PI3K/AKT/mTOR Pathway.

Jie HuangXiaoling FuQiang XuePeng MaYating YinMinjie JiangYunpeng LuQi YingJun JiangHua HeDa Wu
Published in: Disease markers (2023)
This study identifies 6 new prognostic biomarkers for glioma patients. Among them, peptide ARHGEF9 gene is an inhibitory gene functioning by targeting PI3K/AKT/mTOR pathway.
Keyphrases
  • genome wide
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • gene expression